Laddar...
Pathogenesis, Emerging therapeutic targets and Treatment in Sialidosis
INTRODUCTION: Sialidosis is a neurosomatic, lysosomal storage disease (LSD) caused by mutations in the NEU1 gene, encoding the lysosomal sialidase NEU1. Deficient enzyme activity results in impaired processing/degradation of sialo-glycoproteins, and accumulation of oversialylated metabolites. Sialid...
Sparad:
| I publikationen: | Expert Opin Orphan Drugs |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4777310/ https://ncbi.nlm.nih.gov/pubmed/26949572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/21678707.2015.1025746 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|